COVID-19: ACE, Targeted Therapies, Old & New Medicines

This episode talks about research about COVID-19, angiotensin converting enzyme (ACE), and targeted therapies, and our feature is an interview with CU-Boulder scientists Anushree Chatterjee and Prashant Nagpal. This husband and wife science team explains why there may be a downside to adapting old medications to fight Covid-19.  They’ll also explain their anguish about why creating new “drugs” to fight Covid-19 … Continue reading "COVID-19: ACE, Targeted Therapies, Old & New Medicines"